S M Finegold

3.2k total citations
61 papers, 2.5k citations indexed

About

S M Finegold is a scholar working on Infectious Diseases, Clinical Biochemistry and Public Health, Environmental and Occupational Health. According to data from OpenAlex, S M Finegold has authored 61 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Infectious Diseases, 18 papers in Clinical Biochemistry and 17 papers in Public Health, Environmental and Occupational Health. Recurrent topics in S M Finegold's work include Bacterial Identification and Susceptibility Testing (18 papers), Streptococcal Infections and Treatments (16 papers) and Clostridium difficile and Clostridium perfringens research (12 papers). S M Finegold is often cited by papers focused on Bacterial Identification and Susceptibility Testing (18 papers), Streptococcal Infections and Treatments (16 papers) and Clostridium difficile and Clostridium perfringens research (12 papers). S M Finegold collaborates with scholars based in United States, Finland and France. S M Finegold's co-authors include W. Lance George, Paul H. Edelstein, Rial D. Rolfe, Vera L. Sutter, T Somer, Roxanne Meyer, Hannah M. Wexler, Maury E. Mulligan, M A Edelstein and J. F. Murray and has published in prestigious journals such as The Lancet, American Journal of Clinical Nutrition and Applied and Environmental Microbiology.

In The Last Decade

S M Finegold

61 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S M Finegold United States 29 829 607 534 478 345 61 2.5k
D. M. MacLaren Netherlands 29 504 0.6× 662 1.1× 752 1.4× 673 1.4× 196 0.6× 104 2.8k
N Lambert-Zechovsky France 27 635 0.8× 362 0.6× 582 1.1× 593 1.2× 447 1.3× 115 2.2k
J. G. McCormack Australia 24 899 1.1× 403 0.7× 406 0.8× 1.3k 2.7× 275 0.8× 78 3.5k
C. L. Wells United States 23 715 0.9× 490 0.8× 189 0.4× 342 0.7× 189 0.5× 52 2.0k
Brita Bruun Denmark 27 788 1.0× 436 0.7× 591 1.1× 1.0k 2.2× 280 0.8× 99 2.6k
J Fleurette France 29 1.4k 1.6× 961 1.6× 813 1.5× 698 1.5× 354 1.0× 198 2.9k
D. van der Waaij Netherlands 29 936 1.1× 1.1k 1.8× 300 0.6× 656 1.4× 106 0.3× 113 3.5k
Claude–James Soussy France 28 716 0.9× 566 0.9× 333 0.6× 888 1.9× 160 0.5× 82 3.0k
R. A. Shooter United Kingdom 29 714 0.9× 410 0.7× 526 1.0× 501 1.0× 144 0.4× 97 2.5k
Gerda Verschraegen Belgium 38 671 0.8× 896 1.5× 689 1.3× 1.6k 3.3× 391 1.1× 109 3.9k

Countries citing papers authored by S M Finegold

Since Specialization
Citations

This map shows the geographic impact of S M Finegold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S M Finegold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S M Finegold more than expected).

Fields of papers citing papers by S M Finegold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S M Finegold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S M Finegold. The network helps show where S M Finegold may publish in the future.

Co-authorship network of co-authors of S M Finegold

This figure shows the co-authorship network connecting the top 25 collaborators of S M Finegold. A scholar is included among the top collaborators of S M Finegold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S M Finegold. S M Finegold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Summanen, Paula, Paul A. Lawson, & S M Finegold. (2009). Porphyromonas bennonis sp. nov., isolated from human clinical specimens. INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY. 59(7). 1727–1732. 18 indexed citations
3.
Wexler, Hannah M., D. S. Reeves, E Molitoris, et al.. (1996). Sutterella wadsworthensis gen. nov., sp. nov., Bile-Resistant Microaerophilic Campylobacter gracilis-Like Clinical Isolates. International Journal of Systematic Bacteriology. 46(1). 252–258. 58 indexed citations
4.
Summanen, Paula, Hannele Jousimies–Somer, David A. Bruckner, et al.. (1995). Bilophila wadsworthia Isolates from Clinical Specimens. Clinical Infectious Diseases. 20(Supplement_2). S210–S211. 15 indexed citations
5.
Somer, T & S M Finegold. (1995). Vasculitides Associated with Infections, Immunization, and Antimicrobial Drugs. Clinical Infectious Diseases. 20(4). 1010–1036. 150 indexed citations
6.
Finegold, S M. (1993). The importance of black-pigmented Gram-negative anaerobes in human infections. FEMS Immunology & Medical Microbiology. 6(2-3). 77–82. 3 indexed citations
7.
Finegold, S M. (1993). Host factors predisposing to anaerobic infections. FEMS Immunology & Medical Microbiology. 6(2-3). 159–163. 1 indexed citations
8.
Bennion, Robert S., et al.. (1990). Gangrenous and perforated appendicitis with peritonitis: treatment and bacteriology.. PubMed. 12 Suppl C. 31–44. 63 indexed citations
9.
Goldstein, Ellie J. C., et al.. (1986). Susceptibility of bite wound bacteria to seven oral antimicrobial agents, including RU-985, a new erythromycin: considerations in choosing empiric therapy. Antimicrobial Agents and Chemotherapy. 29(4). 556–559. 34 indexed citations
10.
Roberts, Marilyn C., E. J. Baron, S M Finegold, & G E Kenny. (1985). Antigenic distinctiveness of Mobiluncus curtisii and Mobiluncus mulieris. Journal of Clinical Microbiology. 21(6). 891–893. 10 indexed citations
11.
George, W. Lance, Barbara D. Kirby, Vera L. Sutter, et al.. (1982). Intravenous metronidazole for treatment of infections involving anaerobic bacteria. Antimicrobial Agents and Chemotherapy. 21(3). 441–449. 18 indexed citations
12.
George, W. Lance, Rial D. Rolfe, & S M Finegold. (1982). Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions. Journal of Clinical Microbiology. 15(6). 1049–1053. 115 indexed citations
13.
Vesely, David L., Karl D. Straub, Claire M. Nolan, et al.. (1981). Purified Clostridium difficile cytotoxin stimulates guanylate cyclase activity and inhibits adenylate cyclase activity. Infection and Immunity. 33(1). 285–291. 39 indexed citations
14.
Finegold, S M, et al.. (1981). New medium selective for Fusobacterium species and differential for Fusobacterium necrophorum. Journal of Clinical Microbiology. 13(4). 666–669. 23 indexed citations
15.
Goldstein, Ellie J. C., Vera L. Sutter, Yung-Yuan Kwok, Robert P. Lewis, & S M Finegold. (1981). Effect of carbon dioxide on in vitro susceptibility of anaerobic bacteria to erythromycin. Antimicrobial Agents and Chemotherapy. 20(6). 705–708. 18 indexed citations
16.
Edelstein, Paul H. & S M Finegold. (1979). Use of a semiselective medium to culture Legionella pneumophila from contaminated lung specimens. Journal of Clinical Microbiology. 10(2). 141–143. 40 indexed citations
17.
Edelstein, Paul H., et al.. (1979). ISOLATION OF LEGIONELLA PNEUMOPHILA FROM BLOOD. The Lancet. 313(8119). 750–751. 55 indexed citations
18.
Sutter, Vera L., et al.. (1979). In Vitro Activity of Cefoxitin and Parenterally Administered Cephalosporins against Anaerobic Bacteria. Clinical Infectious Diseases. 1(1). 218–223. 9 indexed citations
19.
Brook, Itzhak & S M Finegold. (1978). Acute Suppurative Parotitis Caused by Anaerobic Bacteria: Report of Two Cases. PEDIATRICS. 62(6). 1019–1020. 31 indexed citations
20.
George, W. Lance, et al.. (1978). ÆTIOLOGY OF ANTIMICROBIAL-AGENT-ASSOCIATED COLITIS. The Lancet. 311(8068). 802–803. 156 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. M. MacLaren Breakdown of academic impact, for papers by N Lambert-Zechovsky Breakdown of academic impact, for papers by J. G. McCormack Breakdown of academic impact, for papers by C. L. Wells Breakdown of academic impact, for papers by Brita Bruun Breakdown of academic impact, for papers by J Fleurette Breakdown of academic impact, for papers by D. van der Waaij Breakdown of academic impact, for papers by Claude–James Soussy Breakdown of academic impact, for papers by R. A. Shooter Breakdown of academic impact, for papers by Gerda Verschraegen
Rankless by CCL
2026